Zambia: A Narrative Review of Success and Challenges in Lymphatic Filariasis Elimination

dc.contributor.authorChimfwembe Kingford
dc.contributor.authorShirley Hugh
dc.contributor.authorBaker Natalie
dc.contributor.authorWamai Richard
dc.date.accessioned2025-09-17T10:25:19Z
dc.date.issued2024-1-15
dc.description.abstract<jats:p>The establishment of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) to stop the transmission of infection has significantly reduced the incidence of lymphatic filariasis, a debilitating mosquito-borne neglected tropical disease. The primary strategies that have been employed include mass drug administration (MDA) of anthelminthics and morbidity management and disability prevention (MMDP). While some countries have been able to reach elimination status in Africa, there is still active transmission of LF in Zambia. The nematode responsible for the disease is Wuchereria bancrofti, which is transmitted by Anopheles mosquitoes. To alleviate the suffering of those infected by the disease, the Zambian Ministry of Health launched a program to eliminate LF as a public health problem in 2003. This project reviewed the efforts to achieve the elimination of LF in Zambia, past and present government policies, and the anticipated challenges. MDAs have been conducted since 2014 and coverage has been between 87% and 92%. Zambia has now moved towards pre-transmission assessment surveys (PRETAS) and transmission assessment surveys (TAS). MMDP is a major priority and planned to be conducted between 2022 and 2026. COVID-19 presented a new challenge in the control of LF, while climate change, immigration, co-infections, and funding limitations will complicate further progress.</jats:p>
dc.identifier.doi10.3390/tropicalmed9010021
dc.identifier.urihttps://pubs.cidrz.org/handle/123456789/11731
dc.identifier.uri.pubmedhttps://doi.org/10.3390/tropicalmed9010021
dc.relation.affiliationDepartment of Research and Postgraduate Studies, Chreso University, Lusaka 37178, Zambia
dc.relation.affiliationMinistry of Health, Lusaka 10101, Zambia
dc.relation.affiliationProgram in Medical Education, Harvard Medical School, Boston, MA 02115, USA
dc.relation.affiliationAfrican Center for Community Investment in Health, Nginyang P.O. Box 48-30404, Kenya
dc.relation.affiliationProgram in Medical Education, Harvard Medical School, Boston, MA 02115, USA
dc.relation.affiliationAfrican Center for Community Investment in Health, Nginyang P.O. Box 48-30404, Kenya
dc.relation.affiliationIntegrate Initiative for Global Health, Department of Cultures, Societies and Global Studies, College of Social Sciences and Humanities, Northeastern University, Boston, MA 02115, USA
dc.relation.affiliationDepartment of Global and Public Health, University of Nairobi, Nairobi 00100, Kenya
dc.relation.affiliationNigerian Institute of Medical Research, Federal Ministry of Health, Lagos 101212, Nigeria
dc.sourceTropical Medicine and Infectious Disease
dc.titleZambia: A Narrative Review of Success and Challenges in Lymphatic Filariasis Elimination

Files

Collections